These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 194609

  • 1. [Immunological study of glioma. (2) Changes of immunological responses during treatment].
    Sobue H, Tanimura K, Terabayashi T, Minagawa M, Inoue K.
    No To Shinkei; 1976 Jan; 28(1):87-93. PubMed ID: 194609
    [No Abstract] [Full Text] [Related]

  • 2. T cell adoptive immunotherapy of newly diagnosed gliomas.
    Plautz GE, Miller DW, Barnett GH, Stevens GH, Maffett S, Kim J, Cohen PA, Shu S.
    Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
    [Abstract] [Full Text] [Related]

  • 3. [Immunological study of cerebral tumors in vitro].
    Febvre H, Maunoury R, Constans JP.
    Neurochirurgie; 1971 Jun; 17(3):203-7. PubMed ID: 4330107
    [No Abstract] [Full Text] [Related]

  • 4. The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.
    Papanastassiou V, Rampling R, Fraser M, Petty R, Hadley D, Nicoll J, Harland J, Mabbs R, Brown M.
    Gene Ther; 2002 Mar; 9(6):398-406. PubMed ID: 11960316
    [Abstract] [Full Text] [Related]

  • 5. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL, Mahaley MS, Day ED.
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract] [Full Text] [Related]

  • 6. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS.
    Proc Natl Cancer Conf; 1972 Mar; 7():811-5. PubMed ID: 4358071
    [No Abstract] [Full Text] [Related]

  • 7. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P, Lapras C.
    Neurochirurgie; 1970 Mar; 16(2):143-70. PubMed ID: 4317954
    [No Abstract] [Full Text] [Related]

  • 8. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
    Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL.
    Cancer Res; 2001 Feb 01; 61(3):842-7. PubMed ID: 11221866
    [Abstract] [Full Text] [Related]

  • 9. [Immunology of brain tumors (author's transl)].
    Takakura K.
    No To Shinkei; 1976 Jun 01; 28(6):525-37. PubMed ID: 194610
    [No Abstract] [Full Text] [Related]

  • 10. [Immunogenic properties of human brain glioma antigens evaluated with rabbit sera by means of a complement fixation test].
    Rybarska I.
    Neuropatol Pol; 1975 Jun 01; 13(2):183-94. PubMed ID: 167322
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr 01; 12(4):913-20. PubMed ID: 3885862
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP, Lisianyĭ NI, Prikhodchenko IA.
    Zh Vopr Neirokhir Im N N Burdenko; 1983 Apr 01; (3):56-9. PubMed ID: 6310917
    [No Abstract] [Full Text] [Related]

  • 16. [Characteristics and immunologic changes in patients with malignant brain tumors].
    Khonina NA, Tsentner MI, Leplina OIu, Tikhonova MA, Stupak VV, Nikonov SD, Chërnykh ER, Ostanin AA.
    Vopr Onkol; 2002 Apr 01; 48(2):196-201. PubMed ID: 12227068
    [Abstract] [Full Text] [Related]

  • 17. Immune responses in patients with gliomas.
    Brooks WH, Caldwell HD, Mortara RH.
    Surg Neurol; 1974 Nov 01; 2(6):419-23. PubMed ID: 4372736
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Humoral and cellular immunity in patients with left- and right-sided intracerebral tumors].
    Lisianyĭ NI, Markova OV, Prikhodchenko IA, Primushko LI.
    Zh Vopr Neirokhir Im N N Burdenko; 1989 Nov 01; (2):33-5. PubMed ID: 2787570
    [Abstract] [Full Text] [Related]

  • 20. [Cellular immunity of the patients with malignant glioma -- with special reference to the depressed cell-mediated immunity of the cerebrospinal (author's transl)].
    Uemura S, Wada S, Kodama T, Matsukado Y.
    No Shinkei Geka; 1977 Aug 01; 5(9):931-9. PubMed ID: 303336
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.